Chiara Lanzillotta

Pubblicazioni

Titolo Pubblicato in Anno
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome REDOX BIOLOGY 2019
Targeting mitochondria in Alzheimer disease: rationale and perspectives CNS DRUGS 2019
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models JOURNAL OF ALZHEIMER'S DISEASE 2018
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE 2018
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection FREE RADICAL BIOLOGY & MEDICINE 2018
Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies EXPERT REVIEW OF NEUROTHERAPEUTICS 2018
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome TRANSLATIONAL NEURODEGENERATION 2018
Oxidative stress, protein modification and Alzheimer disease BRAIN RESEARCH BULLETIN 2017
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies EXPERT REVIEW OF NEUROTHERAPEUTICS 2017
Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach NEUROBIOLOGY OF AGING 2017
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome NEURODEGENERATIVE DISEASES 2016
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype JOURNAL OF ALZHEIMER'S DISEASE 2016

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma